Literature DB >> 19456235

Prospective study of vaginal bacterial flora and other risk factors for vulvovaginal candidiasis.

R Scott McClelland1, Barbra A Richardson, Wisal M Hassan, Susan M Graham, James Kiarie, Jared M Baeten, Kishorchandra Mandaliya, Walter Jaoko, Jeckoniah O Ndinya-Achola, King K Holmes.   

Abstract

BACKGROUND: It has been suggested that vaginal colonization with lactobacilli may reduce the risk of vulvovaginal candidiasis (VVC), but supporting data are limited. Our objective was to determine the relationship between vaginal bacterial flora and VVC.
METHODS: We conducted a prospective cohort analysis that involved 151 Kenyan sex workers. At monthly follow-up visits, VVC was defined as the presence of yeast buds, pseudohyphae, or both on a wet preparation (including potassium hydroxide preparation) of vaginal secretions. Generalized estimating equations were used to identify correlates of VVC.
RESULTS: Participants returned for a median of 12 visits (interquartile range, 11-12 visits). VVC was identified at 162 visits, including 26 involving symptomatic VVC. Bacterial vaginosis was associated with fewer episodes of VVC (adjusted odds ratio [aOR], 0.29 [95% confidence interval {CI}, 0.16-0.50]). After excluding women with concurrent bacterial vaginosis, another possible cause of vaginal symptoms, the likelihood of symptomatic VVC was higher among those who had had yeast identified on wet preparation of vaginal secretions during the past 60 days (aOR, 4.06 [95% CI, 1.12-14.74]) and those with concurrent vaginal Lactobacillus colonization (aOR, 3.75 [95% CI, 1.30-10.83]).
CONCLUSIONS: Contrary to the commonly posited hypothesis that vaginal Lactobacillus colonization has a protective effect, we found that such colonization was associated with a nearly 4-fold increase in the likelihood of symptomatic VVC.

Entities:  

Mesh:

Year:  2009        PMID: 19456235      PMCID: PMC2743896          DOI: 10.1086/599213

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  35 in total

1.  Cervicovaginal virus secretion in HIV-infected women.

Authors:  D Anderson; P M Johnson
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1994-02

2.  Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis.

Authors:  Jack D Sobel; Daron Ferris; Jane Schwebke; Paul Nyirjesy; Harold C Wiesenfeld; Jeffrey Peipert; David Soper; Suzanne E Ohmit; Sharon L Hillier
Journal:  Am J Obstet Gynecol       Date:  2006-04-21       Impact factor: 8.661

3.  The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania.

Authors:  S H Kapiga; E F Lyamuya; G K Lwihula; D J Hunter
Journal:  AIDS       Date:  1998-01-01       Impact factor: 4.177

4.  Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study.

Authors:  J M Baeten; P M Nyange; B A Richardson; L Lavreys; B Chohan; H L Martin; K Mandaliya; J O Ndinya-Achola; J J Bwayo; J K Kreiss
Journal:  Am J Obstet Gynecol       Date:  2001-08       Impact factor: 8.661

Review 5.  Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations.

Authors:  J D Sobel; S Faro; R W Force; B Foxman; W J Ledger; P R Nyirjesy; B D Reed; P R Summers
Journal:  Am J Obstet Gynecol       Date:  1998-02       Impact factor: 8.661

6.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.

Authors:  R P Nugent; M A Krohn; S L Hillier
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

7.  High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence.

Authors:  Catriona S Bradshaw; Anna N Morton; Jane Hocking; Suzanne M Garland; Margaret B Morris; Lorna M Moss; Leonie B Horvath; Irene Kuzevska; Christopher K Fairley
Journal:  J Infect Dis       Date:  2006-04-26       Impact factor: 5.226

8.  Clinical comparison of microscopic and culture techniques in the diagnosis of Candida vaginitis.

Authors:  J J Bergman; A O Berg; R Schneeweiss; F E Heidrich
Journal:  J Fam Pract       Date:  1984-04       Impact factor: 0.493

9.  Quantification of Candida albicans morphology in vaginal smears.

Authors:  L A Merson-Davies; F C Odds; R Malet; S Young; V Riley; P Schober; P G Fisk
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1991-11-03       Impact factor: 2.435

Review 10.  Vulvovaginal candidosis.

Authors:  Jack D Sobel
Journal:  Lancet       Date:  2007-06-09       Impact factor: 79.321

View more
  29 in total

Review 1.  Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework.

Authors:  Mary Ann Jabra-Rizk; Eric F Kong; Christina Tsui; M Hong Nguyen; Cornelius J Clancy; Paul L Fidel; Mairi Noverr
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

Review 2.  IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans.

Authors:  Heather R Conti; Sarah L Gaffen
Journal:  J Immunol       Date:  2015-08-01       Impact factor: 5.422

3.  Mixed vaginitis-more than coinfection and with therapeutic implications.

Authors:  Jack D Sobel; Chitra Subramanian; Betsy Foxman; Marilyn Fairfax; Scott E Gygax
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

Review 4.  Host responses to Candida albicans: Th17 cells and mucosal candidiasis.

Authors:  Heather R Conti; Sarah L Gaffen
Journal:  Microbes Infect       Date:  2010-04-08       Impact factor: 2.700

Review 5.  Candida infections of the genitourinary tract.

Authors:  Jacqueline M Achkar; Bettina C Fries
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

6.  Is antibiotic prophylaxis necessary before midurethral sling procedures for female stress incontinence? A decision analysis.

Authors:  Jonathan P Shepherd; Keisha A Jones; Oz Harmanli
Journal:  Int Urogynecol J       Date:  2013-08-01       Impact factor: 2.894

7.  The Vaginal Microbiota and Behavioral Factors Associated With Genital Candida albicans Detection in Reproductive-Age Women.

Authors:  Sarah E Brown; Jennifer A Schwartz; Courtney K Robinson; D Elizabeth OʼHanlon; L Latéy Bradford; Xin He; Katrina S Mark; Vincent M Bruno; Jacques Ravel; Rebecca M Brotman
Journal:  Sex Transm Dis       Date:  2019-11       Impact factor: 2.830

8.  The Neutral Vaginal pH in Mice That Is Typical of Most Mammalian Species Should Not Deter Research Using Experimental Murine Models of Candida Vaginitis.

Authors:  Paul L Fidel
Journal:  Infect Immun       Date:  2021-01-19       Impact factor: 3.441

Review 9.  The vaginal mycobiome: A contemporary perspective on fungi in women's health and diseases.

Authors:  L Latéy Bradford; Jacques Ravel
Journal:  Virulence       Date:  2016-09-22       Impact factor: 5.882

10.  Prospective study of correlates of vaginal Lactobacillus colonisation among high-risk HIV-1 seronegative women.

Authors:  J M Baeten; W M Hassan; V Chohan; B A Richardson; K Mandaliya; J O Ndinya-Achola; W Jaoko; R S McClelland
Journal:  Sex Transm Infect       Date:  2009-03-26       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.